UPDATE: Oppenheimer Starts Acasti Pharma (ACST) at Outperform
Tweet Send to a Friend
(Updated - December 21, 2021 4:06 PM EST)
Oppenheimer analyst Leland Gershell initiates coverage on Acasti Pharma (NASDAQ: ACST) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Leland Gershell initiates coverage on Acasti Pharma (NASDAQ: ACST) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
